search
Back to results

Corneal Endothelium After Phacoemulsification in Pseudo Exfoliation Syndrome

Primary Purpose

Corneal Endothelial Cell Loss, Pseudoexfoliation Syndrome

Status
Completed
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
phacoemulsification
Sponsored by
Minia University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Corneal Endothelial Cell Loss focused on measuring corneal endothelial cell loss, pseudoexfoliation syndrome , cataract

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • senile cataract age more than 55 years

Exclusion Criteria:

  • PEX with glaucoma, eyes with cornea guttata or any corneal dystrophy, zonular dehiscence, very dense nuclear cataract (cataracta nigra) history of previous ocular surgery.

Sites / Locations

  • Minia University Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Corneal Endothelial Evaluation after Phacoemulsification in Eyes with Pseudoexfoliation Syndrome

Corneal Endothelial Evaluation after Phacoemulsification in Eyes without Pseudoexfoliation

Arm Description

Outcomes

Primary Outcome Measures

corneal endothelial cell loss
corneal endothelial cell loss

Secondary Outcome Measures

Full Information

First Posted
July 3, 2022
Last Updated
September 8, 2022
Sponsor
Minia University
search

1. Study Identification

Unique Protocol Identification Number
NCT05447130
Brief Title
Corneal Endothelium After Phacoemulsification in Pseudo Exfoliation Syndrome
Official Title
Corneal Endothelial Evaluation After Phacoemulsification in Eyes With Pseudoexfoliation Syndrome
Study Type
Interventional

2. Study Status

Record Verification Date
September 2022
Overall Recruitment Status
Completed
Study Start Date
March 1, 2019 (Actual)
Primary Completion Date
December 20, 2020 (Actual)
Study Completion Date
December 31, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Minia University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
To study corneal endothelial cells changes after phacoemulsification in patients with senile cataract and pseudoexfoliation syndrome (PEX) compared with control patients with senile cataract using specular microscope.
Detailed Description
In a prospective interventional case-control study, 20 eyes with cataract and PEX and 20 control eyes with cataract without PXE were subjected to phacoemulsification and posterior chamber foldable intraocular lens implantation in Minia University Hospital and Genaidy Eye Center between March 2019 and December 2020. Specular microscopy was done preoperatively, 3 and 6 months postoperatively. Endothelium cell density (ECD), coefficient variation (CV), hexagonality, pleomorphism and corneal thickness were evaluated and compares between PXE and control eyes.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Corneal Endothelial Cell Loss, Pseudoexfoliation Syndrome
Keywords
corneal endothelial cell loss, pseudoexfoliation syndrome , cataract

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
40 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Corneal Endothelial Evaluation after Phacoemulsification in Eyes with Pseudoexfoliation Syndrome
Arm Type
Experimental
Arm Title
Corneal Endothelial Evaluation after Phacoemulsification in Eyes without Pseudoexfoliation
Arm Type
Experimental
Intervention Type
Procedure
Intervention Name(s)
phacoemulsification
Intervention Description
phacoemulsification with corneal endothelial evaluation by specular microscopy
Primary Outcome Measure Information:
Title
corneal endothelial cell loss
Description
corneal endothelial cell loss
Time Frame
6 months

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: senile cataract age more than 55 years Exclusion Criteria: PEX with glaucoma, eyes with cornea guttata or any corneal dystrophy, zonular dehiscence, very dense nuclear cataract (cataracta nigra) history of previous ocular surgery.
Facility Information:
Facility Name
Minia University Hospital
City
Minya
State/Province
Minia
ZIP/Postal Code
61111
Country
Egypt

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

Corneal Endothelium After Phacoemulsification in Pseudo Exfoliation Syndrome

We'll reach out to this number within 24 hrs